Fundamental restructuring of the medical-related business following the special investigation
First written in FY2022. 2 of 7 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「In the fiscal year ending March 2027, we will seek sustainable growth by strengthening our business and earnings foundations through the strategic acquisition of new alliance partners and improved profitability of the existing business as the two pillars of our efforts.」
Following the reassessment and restructuring of the business, the policy for the fiscal year ending March 2027 was defined as combining the strategic acquisition of new alliance partners with improved profitability of the existing business. - FY2025ReframedAnnual report
「In the fiscal year ending March 2026, we will seek sustainable growth by strengthening our business and earnings foundations through the strategic acquisition of new alliance partners and improved profitability of the existing business as the two pillars of our efforts.」
Following the reassessment and restructuring of the business, the policy for the fiscal year ending March 2026 has been defined as combining the strategic acquisition of new alliance partners with improved profitability of the existing business. - FY2025-H1AdvancedAnnual report
「Alliance partner medical institutions have a total of 5,180 beds. The 53 alliance partner facilities comprise 6 outpatient clinics without beds, 8 inpatient clinics, 27 hospitals (including long-term care medical facilities), and 12 geriatric health services facilities, an increase from the end of the previous consolidated fiscal year.」
After prioritizing the reassessment and restructuring of the business, the scale of partner medical institutions increased from the end of the previous fiscal year to 53 institutions with 5,180 beds. - FY2024AdvancedAnnual report
「Although we have resumed the acquisition of new alliance partners, which had been suspended since the fiscal year ended March 2023, we were unable to acquire any new alliance partners during the current consolidated fiscal year.」
As part of the business restructuring process, the Company resumed acquiring new alliance partners, which had been suspended since FY2023. However, there were no acquisitions during FY2024. - FY2023-Q2RestatedAnnual report
「This fiscal year, we will not pursue an increase in the number of beds held by medical institutions that are alliance partners, and will focus on reviewing and restructuring the Group's businesses. As a result, no new alliances were acquired during the consolidated first-half cumulative period.」
The policy of reassessing and restructuring the medical-related business following the special investigation continues, and it has been confirmed that the Company is not pursuing an increase in the number of beds or the acquisition of new alliance partners. - FY2023-Q1RestatedAnnual report
「This fiscal year, rather than pursuing an increase in the number of beds at alliance medical institutions, we will focus on reassessing and restructuring the Group's business.」
Regarding the policy of restructuring the medical-related business following the special investigation, the policy of focusing on reassessing and restructuring the business continued to be stated in FY2023-Q1. - FY2022First statedAnnual report
「In light of the establishment of the Special Investigation Committee on 12 May 2022, the dismissal of the Representative Director of グローム・マネジメント株式会社 on 19 May of the same year, and the investigation report received from the Special Investigation Committee on 24 June of that year, we will fundamentally restructure the medical-related business.」
The policy of fundamentally restructuring the medical-related business itself was stated for the first time, following the establishment of the Special Investigation Committee, the dismissal of the representative director of the subsidiary, and receipt of the investigation report.